Wen-Yu Pan Selected Research

Wen-Yu Pan Research Topics

Disease

17	Neoplasms (Cancer) 01/2020 - 09/2002
2	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2010
2	Carcinoma (Carcinomatosis) 10/2013 - 07/2004
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2005 - 07/2004
1	Hyperthermia 01/2020
1	Colitis 11/2018
1	Focal Infection 01/2017
1	Abscess 02/2016
1	Infections 02/2016
1	Wounds and Injuries (Trauma) 02/2016
1	Ischemia 01/2016
1	Myocardial Infarction 12/2015
1	Stomach Neoplasms (Stomach Cancer) 10/2013
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2013
1	Hypoxia (Hypoxemia) 07/2013
1	Acute Promyelocytic Leukemia 12/2011
1	Obesity 10/2011
1	Hepatitis B 11/2010
1	Hepatocellular Carcinoma (Hepatoma) 05/2010
1	Mouth Neoplasms (Oral Cancer) 02/2008
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2008
1	Diabetes Mellitus 02/2008
1	Breast Neoplasms (Breast Cancer) 12/2005
1	Necrosis 07/2004
1	Colonic Neoplasms (Colon Cancer) 07/2003
1	Melanoma (Melanoma, Malignant) 07/2003

Drug/Important Bio-Agent (IBA)

3	Interleukin-12 (IL 12)IBA 05/2012 - 07/2003
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2008 - 11/2003
3	DNA (Deoxyribonucleic Acid)IBA 02/2008 - 11/2003
2	Pharmaceutical PreparationsIBA 02/2016 - 07/2013
2	AntioxidantsIBA 01/2016 - 01/2016
2	trioctyl phosphine oxide (TOPO)IBA 02/2008 - 11/2003
2	2,5- bis(4- hydroxy- 3- methoxybenzylidene)cyclopentanoneIBA 07/2004 - 06/2003
1	AntigensIBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	Capsules (Microcapsules)IBA 11/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Hydroxyl RadicalIBA 02/2016
1	graphene oxideIBA 02/2016
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2016
1	EnzymesIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Superoxide DismutaseIBA 01/2016
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2016
1	Therapeutic UsesIBA 12/2015
1	Copper-Transporting ATPasesIBA 10/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2013
1	Interleukin-6 (Interleukin 6)IBA 10/2013
1	MPT0B098IBA 07/2013
1	Messenger RNA (mRNA)IBA 07/2013
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2013
1	Carmustine (FIVB)FDA Link 12/2011
1	Aligeron (AS 2)IBA 12/2011
1	Arsenic Trioxide (Trisenox)FDA Link 12/2011
1	2,5- bis(5- hydroxymethyl- 2- selenienyl)- 3- hydroxymethyl- N- methylpyrroleIBA 10/2011
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2010
1	VaccinesIBA 11/2010
1	HydrogelsIBA 11/2010
1	AluminumIBA 11/2010
1	CytokinesIBA 05/2010
1	Caspase 8 (Caspase-8)IBA 05/2010
1	chamaecypanone CIBA 05/2010
1	PPAR-gamma AgonistsIBA 02/2008
1	Etoposide (VP 16)FDA LinkGeneric 02/2008
1	2- methyl- 2- ((1- (3- phenyl- 7- propylbenzo(d)isoxazol- 6- yl)oxy)propyl)- 1H- 4- indolyloxypropanoic acidIBA 02/2008
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2008
1	PPAR alphaIBA 02/2008
1	AcridinesIBA 12/2005
1	AldehydesIBA 01/2005
1	Propidium (Propidium Iodide)IBA 07/2004
1	Annexin A5IBA 07/2004
1	CaspasesIBA 07/2004
1	Antineoplastic Agents (Antineoplastics)IBA 07/2004
1	indoleIBA 07/2004
1	Antimitotic AgentsIBA 07/2004
1	6- methoxy- 3- (3',4',5'- trimethoxybenzoyl)- 1H- indoleIBA 07/2004
1	Interleukin-23 (Interleukin 23)IBA 07/2003
1	3- (9- acridinylamino)- 5- hydroxymethylaniline ethylcarbamateIBA 09/2002
1	NetropsinIBA 09/2002

Therapy/Procedure

2	Immunotherapy 01/2020 - 05/2012
1	Therapeutics 01/2020
1	Rectal Administration 11/2018
1	Transplantation 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 12/2011
1	Electroacupuncture 10/2011
1	Catgut 10/2011
1	Acupuncture Points (Acupuncture Point) 10/2011
1	Intravenous Injections 12/2005